Filing Details
- Accession Number:
- 0001264124-12-000107
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-29 20:17:10
- Reporting Period:
- 2012-03-28
- Filing Date:
- 2012-03-29
- Accepted Time:
- 2012-03-29 19:17:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881464 | Amylin Pharmaceuticals Inc | AMLN | Pharmaceutical Preparations (2834) | 330266089 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236395 | A Lloyd Rowland | 9360 Towne Centre Dr San Diego CA 92121 | Vp, Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-28 | 5,000 | $9.02 | 42,603 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-28 | 5,000 | $22.83 | 37,603 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-03-29 | 3,000 | $25.00 | 34,603 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-28 | 5,000 | $22.83 | 5,000 | $9.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,750 | 2016-03-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,665 | Indirect | Indirect-401k |
| Common Stock | 7,974 | Indirect | by ESOP |
Footnotes
- The sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- 25% of shares vested one year from date of grant and the remainder vested monthly over the next three years becoming fully vested four years from date of grant.
Billionaire Hedge Funds
